Hepatitis C virus NS3-4A serine protease complex (NS3/4A)

The Hepatitis C virus (HCV) NS3-4A serine protease complex is a critical heterodimeric enzyme composed of the N-terminal domain of the non-structural protein 3 (NS3) and the NS4A cofactor (NIH, 2021). This complex is indispensable for the viral life cycle, as it performs the proteolytic cleavage of the HCV polyprotein at four specific junctions to release mature non-structural proteins (NS4B, NS5A, and NS5B) necessary for viral replication (MDPI, 2024). In addition to its role in polyprotein processing, the NS3-4A protease contributes to viral pathogenesis by cleaving host cell adaptor proteins, such as MAVS and TRIF, which effectively blocks the induction of the host's innate immune response (ASM, 2014). As a result, the NS3-4A complex has become a primary therapeutic target for direct-acting antiviral (DAA) agents (PLOS, 2012). Protease inhibitors, such as glecaprevir and grazoprevir, bind to the active site of the enzyme to halt viral replication and restore immune signaling (NIH, 2011). Despite the high efficacy of modern DAA regimens, the emergence of resistance-associated substitutions and the potential for significant drug-drug interactions remain key challenges in clinical management (RxList, 2021).

Other names

HCV NS3/4A proteaseNS3-4A serine proteaseNS3-4A complexNS3-4A heterodimerHepatitis C virus non-structural protein 3-4A complex

Inhibition of the NS3/4A serine protease activity, preventing the proteolytic processing of the HCV polyprotein into mature non-structural proteins, which is essential for viral replication and assembly (NIH, 2011).